| Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications N Banu, SS Panikar, LR Leal, AR Leal Life sciences 256, 117905, 2020 | 171 | 2020 |
| Anti-fouling SERS-based immunosensor for point-of-care detection of the B7–H6 tumor biomarker in cervical cancer patient serum SS Panikar, N Banu, J Haramati, GY Gutierrez-Silerio, ... Analytica Chimica Acta 1138, 110-122, 2020 | 42 | 2020 |
| Novel anti-HER2 peptide-conjugated theranostic nanoliposomes combining NaYF 4: Yb, Er nanoparticles for NIR-activated bioimaging and chemo-photodynamic therapy against breast … SS Panikar, G Ramírez-García, AA Vallejo-Cardona, N Banu, ... Nanoscale 11 (43), 20598-20613, 2019 | 39 | 2019 |
| Nanobodies as efficient drug-carriers: progress and trends in chemotherapy SS Panikar, N Banu, J Haramati, S del Toro-Arreola, AR Leal, P Salas Journal of Controlled Release 334, 389-412, 2021 | 31 | 2021 |
| Stealth modified bottom up SERS substrates for label-free therapeutic drug monitoring of doxorubicin in blood serum SS Panikar, N Banu, ER Escobar, GR García, J Cervantes-Martínez, ... Talanta 218, 121138, 2020 | 28 | 2020 |
| Ligand-targeted Theranostic Liposomes combining Methylene Blue attached Upconversion nanoparticles for NIR activated Bioimaging and Photodynamic therapy against HER-2 positive … SS Panikar, G Ramírez-García, N Banu, AA Vallejo-Cardona, ... Journal of Luminescence 237, 118143, 2021 | 20 | 2021 |
| Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis F Solorzano-Ibarra, AG Alejandre-Gonzalez, PC Ortiz-Lazareno, ... Clinical & Experimental Immunology 204 (1), 78-95, 2021 | 11 | 2021 |
| B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical … N Banu, A Riera-Leal, J Haramati, PC Ortiz-Lazareno, SS Panikar, ... BMC cancer 20, 1-11, 2020 | 11 | 2020 |
| Non‐fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients GY Gutierrez‐Silerio, MR Bueno‐Topete, AN Vega‐Magaña, ... Immunology 168 (3), 538-553, 2023 | 3 | 2023 |
| Immune checkpoint expression on peripheral lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis FS Ibarra, AA González, PO Lazareno, BB Ramirez, AZ Moreno, ... Authorea Preprints, 2020 | | 2020 |
| B7H6, an immunoligand for natural killer cell receptor NKp30, not only activates NK cells, but also demonstrates inhibitory effects on tumor cell proliferation and migration N Banu, A Riera-Leal, J Haramati, PC Ortiz-Lazareno, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 45-45, 2019 | | 2019 |
Sandeep Surendra PanikarWashington University of Medical SchoolVerified email at wustl.edu
Sandeep Surendra PanikarWashington University of Medical SchoolVerified email at wustl.edu